Integer Holdings Corporation (ITGR)
USD 131.5
(-3.79%)
USD 131.5
(-3.79%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1.59 Billion USD | 16.03% |
| 2022 | 1.37 Billion USD | 12.7% |
| 2021 | 1.22 Billion USD | 13.75% |
| 2020 | 1.07 Billion USD | -14.68% |
| 2019 | 1.25 Billion USD | 3.55% |
| 2018 | 1.21 Billion USD | -16.89% |
| 2017 | 1.46 Billion USD | 5.42% |
| 2016 | 1.38 Billion USD | 73.26% |
| 2015 | 800.41 Million USD | 16.38% |
| 2014 | 687.78 Million USD | 3.59% |
| 2013 | 663.94 Million USD | 2.75% |
| 2012 | 646.17 Million USD | 13.6% |
| 2011 | 568.82 Million USD | 6.64% |
| 2010 | 533.42 Million USD | 2.22% |
| 2009 | 521.82 Million USD | -4.54% |
| 2008 | 546.64 Million USD | 71.5% |
| 2007 | 318.74 Million USD | 17.56% |
| 2006 | 271.14 Million USD | 12.46% |
| 2005 | 241.09 Million USD | 20.48% |
| 2004 | 200.11 Million USD | -7.51% |
| 2003 | 216.36 Million USD | 29.33% |
| 2002 | 167.29 Million USD | 23.4% |
| 2001 | 135.57 Million USD | 38.64% |
| 2000 | 97.79 Million USD | 23.42% |
| 1999 | 79.23 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 414.79 Million USD | 0.4% |
| 2024 Q2 | 436.57 Million USD | 5.25% |
| 2024 Q3 | 431.41 Million USD | -1.18% |
| 2023 Q3 | 404.69 Million USD | 1.16% |
| 2023 FY | 1.59 Billion USD | 16.03% |
| 2023 Q4 | 413.15 Million USD | 2.09% |
| 2023 Q1 | 378.78 Million USD | 1.71% |
| 2023 Q2 | 400.04 Million USD | 5.61% |
| 2022 Q1 | 310.91 Million USD | -0.67% |
| 2022 FY | 1.37 Billion USD | 12.7% |
| 2022 Q4 | 372.42 Million USD | 8.68% |
| 2022 Q3 | 342.68 Million USD | -2.11% |
| 2022 Q2 | 350.08 Million USD | 12.6% |
| 2021 FY | 1.22 Billion USD | 13.75% |
| 2021 Q3 | 305.57 Million USD | -2.07% |
| 2021 Q4 | 313.01 Million USD | 2.44% |
| 2021 Q1 | 290.46 Million USD | 8.0% |
| 2021 Q2 | 312.02 Million USD | 7.42% |
| 2020 Q4 | 268.95 Million USD | 13.99% |
| 2020 Q2 | 240.11 Million USD | -26.89% |
| 2020 Q1 | 328.42 Million USD | 0.86% |
| 2020 FY | 1.07 Billion USD | -14.68% |
| 2020 Q3 | 235.94 Million USD | -1.74% |
| 2019 Q1 | 314.67 Million USD | 3.84% |
| 2019 Q4 | 325.63 Million USD | 7.26% |
| 2019 Q2 | 314.19 Million USD | -0.15% |
| 2019 Q3 | 303.58 Million USD | -3.38% |
| 2019 FY | 1.25 Billion USD | 3.55% |
| 2018 FY | 1.21 Billion USD | -16.89% |
| 2018 Q4 | 303.03 Million USD | -0.67% |
| 2018 Q3 | 305.08 Million USD | -2.98% |
| 2018 Q2 | 314.46 Million USD | -17.62% |
| 2018 Q1 | 381.74 Million USD | -2.24% |
| 2017 Q2 | 362.71 Million USD | 5.01% |
| 2017 Q3 | 363.3 Million USD | 0.16% |
| 2017 Q4 | 390.48 Million USD | 7.48% |
| 2017 FY | 1.46 Billion USD | 5.42% |
| 2017 Q1 | 345.41 Million USD | -3.94% |
| 2016 FY | 1.38 Billion USD | 73.26% |
| 2016 Q1 | 332.23 Million USD | 4.62% |
| 2016 Q2 | 348.38 Million USD | 4.86% |
| 2016 Q3 | 346.56 Million USD | -0.52% |
| 2016 Q4 | 359.59 Million USD | 3.76% |
| 2015 Q3 | 146.63 Million USD | -16.15% |
| 2015 Q1 | 161.32 Million USD | -4.95% |
| 2015 Q4 | 317.56 Million USD | 116.57% |
| 2015 FY | 800.41 Million USD | 16.38% |
| 2015 Q2 | 174.89 Million USD | 8.41% |
| 2014 Q3 | 171.69 Million USD | -0.22% |
| 2014 Q2 | 172.08 Million USD | -1.26% |
| 2014 Q1 | 174.28 Million USD | -1.32% |
| 2014 FY | 687.78 Million USD | 3.59% |
| 2014 Q4 | 169.72 Million USD | -1.15% |
| 2013 Q3 | 167.73 Million USD | -2.1% |
| 2013 FY | 663.94 Million USD | 2.75% |
| 2013 Q4 | 176.61 Million USD | 5.3% |
| 2013 Q2 | 171.33 Million USD | 15.56% |
| 2013 Q1 | 148.26 Million USD | -6.86% |
| 2012 Q3 | 161.34 Million USD | -3.13% |
| 2012 FY | 646.17 Million USD | 13.6% |
| 2012 Q2 | 166.54 Million USD | 4.68% |
| 2012 Q1 | 159.1 Million USD | 12.25% |
| 2012 Q4 | 159.18 Million USD | -1.34% |
| 2011 Q3 | 131.71 Million USD | -10.1% |
| 2011 FY | 568.82 Million USD | 6.64% |
| 2011 Q4 | 141.74 Million USD | 7.61% |
| 2011 Q2 | 146.52 Million USD | -1.55% |
| 2011 Q1 | 148.83 Million USD | 11.81% |
| 2010 FY | 533.42 Million USD | 2.22% |
| 2010 Q2 | 140.79 Million USD | 6.64% |
| 2010 Q1 | 132.02 Million USD | 4.94% |
| 2010 Q4 | 133.11 Million USD | 4.41% |
| 2010 Q3 | 127.49 Million USD | -9.45% |
| 2009 Q3 | 121.47 Million USD | -9.84% |
| 2009 FY | 521.82 Million USD | -4.54% |
| 2009 Q4 | 125.8 Million USD | 3.57% |
| 2009 Q2 | 134.72 Million USD | -3.64% |
| 2009 Q1 | 139.81 Million USD | -4.63% |
| 2008 Q4 | 146.6 Million USD | 7.6% |
| 2008 Q3 | 136.24 Million USD | -3.82% |
| 2008 Q2 | 141.64 Million USD | 15.96% |
| 2008 Q1 | 122.15 Million USD | 44.71% |
| 2008 FY | 546.64 Million USD | 71.5% |
| 2007 Q1 | 76.86 Million USD | 21.72% |
| 2007 Q2 | 78.46 Million USD | 2.08% |
| 2007 Q3 | 79 Million USD | 0.7% |
| 2007 Q4 | 84.41 Million USD | 6.84% |
| 2007 FY | 318.74 Million USD | 17.56% |
| 2006 FY | 271.14 Million USD | 12.46% |
| 2006 Q4 | 63.14 Million USD | -8.88% |
| 2006 Q3 | 69.29 Million USD | -1.85% |
| 2006 Q1 | 68.1 Million USD | 15.72% |
| 2006 Q2 | 70.59 Million USD | 3.66% |
| 2005 FY | 241.09 Million USD | 20.48% |
| 2005 Q4 | 58.85 Million USD | -5.61% |
| 2005 Q3 | 62.35 Million USD | -1.84% |
| 2005 Q2 | 63.52 Million USD | 12.72% |
| 2005 Q1 | 56.35 Million USD | 21.27% |
| 2004 FY | 200.11 Million USD | -7.51% |
| 2004 Q3 | 45.17 Million USD | -14.67% |
| 2004 Q4 | 46.47 Million USD | 2.87% |
| 2004 Q2 | 52.94 Million USD | -4.65% |
| 2004 Q1 | 55.52 Million USD | 12.46% |
| 2003 Q1 | 54.85 Million USD | 15.94% |
| 2003 FY | 216.36 Million USD | 29.33% |
| 2003 Q4 | 49.37 Million USD | -12.36% |
| 2003 Q3 | 56.33 Million USD | 0.96% |
| 2003 Q2 | 55.8 Million USD | 1.72% |
| 2002 Q2 | 38.32 Million USD | 5.58% |
| 2002 Q1 | 36.3 Million USD | 4.64% |
| 2002 FY | 167.29 Million USD | 23.4% |
| 2002 Q4 | 47.31 Million USD | 4.33% |
| 2002 Q3 | 45.35 Million USD | 18.32% |
| 2001 Q1 | 29.57 Million USD | 5.8% |
| 2001 FY | 135.57 Million USD | 38.64% |
| 2001 Q2 | 32.98 Million USD | 11.55% |
| 2001 Q3 | 38.32 Million USD | 16.18% |
| 2001 Q4 | 34.69 Million USD | -9.48% |
| 2000 Q3 | 23.25 Million USD | 0.0% |
| 2000 Q4 | 27.95 Million USD | 20.18% |
| 2000 FY | 97.79 Million USD | 23.42% |
| 1999 FY | 79.23 Million USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Abbott Laboratories | 40.1 Billion USD | 96.019% |
| Allurion Technologies Inc. | 53.46 Million USD | -2886.278% |
| Artivion, Inc. | 354 Million USD | -351.032% |
| Avanos Medical, Inc. | 673.3 Million USD | -137.141% |
| Butterfly Network, Inc. | 65.9 Million USD | -2322.873% |
| Butterfly Network, Inc. | 65.9 Million USD | -2322.873% |
| Bio-Rad Laboratories, Inc. | 2.67 Billion USD | 40.228% |
| Boston Scientific Corporation | 14.24 Billion USD | 88.787% |
| Perspective Therapeutics, Inc. | 7.1 Million USD | -22375.69% |
| CONMED Corporation | 1.24 Billion USD | -28.665% |
| Edwards Lifesciences Corporation | 6 Billion USD | 73.41% |
| Paragon 28, Inc. | 216.38 Million USD | -637.872% |
| Glaukos Corporation | 314.71 Million USD | -407.346% |
| Globus Medical, Inc. | 1.56 Billion USD | -1.798% |
| Inspire Medical Systems, Inc. | 624.79 Million USD | -155.55% |
| Medtronic plc | 32.36 Billion USD | 95.067% |
| Nevro Corp. | 425.17 Million USD | -275.534% |
| Owlet, Inc. | 54.01 Million USD | -2856.254% |
| Penumbra, Inc. | 1.05 Billion USD | -50.84% |
| Vicarious Surgical Inc. | - USD | -Infinity% |
| Smith & Nephew plc | 5.54 Billion USD | 71.226% |
| Sonendo, Inc. | 43.86 Million USD | -3539.97% |
| STERIS plc | 5.13 Billion USD | 68.928% |
| Stryker Corporation | 20.49 Billion USD | 92.211% |
| Vapotherm, Inc. | 68.66 Million USD | -2225.173% |
| Zimmer Biomet Holdings, Inc. | 7.39 Billion USD | 78.406% |